Gujarat Kidney And Super Speciality Limited (NSE:GKSL)

India · Delayed Price · Currency is INR

171.09

-2.13 (-1.23%)

At close: Sep 11, 2026

Market Cap	13.49B
Revenue (ttm)	1.01B +118.9%
Net Income	158.34M +38.4%
EPS	2.34 +10.2%
Shares Out	78.84M
PE Ratio	73.06
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	120,195
Open	174.35
Previous Close	173.22
Day's Range	170.00 - 176.45
52-Week Range	98.36 - 180.90
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About NSE:GKSL

Gujarat Kidney and Super Speciality Limited operates multi-specialty and super-specialty hospitals in India. It provides treatment for Oncology, Neurology, Gastroenterology, Urology, Nephrology, and Physiotherapy. It also offers Renal Surgery, Vascular Surgery, Gynecology and obstetrics, Robotic Surgery, Bariatric Surgery, Laparoscopic Surgery, Endocrine Surgery, Neurosurgery, and Joint Replacement services. Its facilities include intensive care unit, rooms, patient counselling, operation theatres, and dialysis center. Gujarat Kidney And Super ... [Read more]

Industry Medical Care Facilities

Sector Healthcare

Founded 2014

Country India

Stock Exchange National Stock Exchange of India

Ticker Symbol GKSL

Full Company Profile

Financial Performance

In fiscal year 2026, NSE:GKSL's revenue was 820.13 million, an increase of 103.80% compared to the previous year's 402.42 million. Earnings were 154.97 million, an increase of 64.63%.

Financial Statements